effects on vision: - accomodation - visual acuity - binocularity - stereopsis - colour vision - pupil reflex - eye movements
Conditions
Interventions
Trade Name: Nitrous oxide
Product Name: nitrous oxide
Pharmaceutical Form: Medicinal gas, compressed
INN or Proposed INN: nitrous oxide
CAS Number: 10024-97-2
Other descriptive name: NITROUS OXIDE
Con
Sponsors
Universitair ziekenhuis Brussel
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Subjects between 18 and 25 years old - Men and women in good health (ASA I). Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - Younger than 18 years or older than 25 years - Sick people or people having a cold (risk for the eardrum) - volunteers with lung disorders (because of the inhalation of the gas) - No pregnant subjects. - At least 24 h before the experiment, volunteers should be free of party drugs or other medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To examine the effects of nitrous oxide on human vision ;Secondary Objective: N/A;Primary end point(s): Visus;Timepoint(s) of evaluation of this end point: After 10 minutes of administration of nitrous oxide | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): - accommodation - binocularity - stereopsis - colour vision - pupil reflex - eye movements. - Alteration of mental status;Timepoint(s) of evaluation of this end point: After 10 minutes of administration of nitrous oxide | — |
Countries
Belgium
Contacts
Public ContactStudycoordinator
Universitair Ziekenhuis Brussel
Outcome results
None listed